Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cholinesterase Inhibitors

Known as: Anti-Cholinesterases, Inhibitors, Cholinesterase, anti cholinesterase 
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND Cholinesterase inhibitors are commonly prescribed to treat dementia, but their adverse effect profile has received… Expand
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Review
2006
Review
2006
AbstractHuperzine A (HupA), a novel alkaloid isolated from the Chinese herb Huperzia serrata, is a potent, highly specific and… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Review
2005
Review
2005
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2004
Review
2004
An important aspect of brain cholinesterase function is related to enzymatic differences. The brain of mammals contains two major… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
CONTEXT Memantine is a low- to moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist. Controlled trials have… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2003
Review
2003
BACKGROUND Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite… Expand
Is this relevant?
Review
2002
Review
2002
Cholinesterase inhibitors are the ‘first-line’ agents in the treatment of Alzheimer’s disease. This article presents the latest… Expand
Is this relevant?
Review
1998
Review
1998
New cholinesterase inhibitors capable of slowing the progression of Alzheimer's disease are being introduced at a rapid pace. In… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Data generated to date by a number of large studies (Eagger et al, Davis et al, Farlow et al, and Murphy et al) indicate that… Expand
Is this relevant?